Ioflupane I-123 Completed Phase 2 Trials for Parkinson's Disease (PD) Other

IndicationsStatusPurposePhase
CompletedOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT01141023Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression